| For: | Martin J, Dufour JF. Tumor suppressor and hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1720-1733 [PMID: 18350603 DOI: 10.3748/wjg.14.1720] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1720.htm |
| Number | Citing Articles |
| 1 |
Igor P. Pogribny, Svitlana I. Shpyleva, Levan Muskhelishvili, Tetyana V. Bagnyukova, S. Jill James, Frederick A. Beland. Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2009; 669(1-2) doi: 10.1016/j.mrfmmm.2009.05.003
|
| 2 |
Srimanta Patra, Prajna Paramita Naik, Kewal Kumar Mahapatra, Moureq Rashed Alotaibi, Shankargouda Patil, Birija Sankar Patro, Gautam Sethi, Thomas Efferth, Sujit Kumar Bhutia. Recent advancement of autophagy in polyploid giant cancer cells and its interconnection with senescence and stemness for therapeutic opportunities. Cancer Letters 2024; 590 doi: 10.1016/j.canlet.2024.216843
|
| 3 |
. 2013; doi: 10.70675/bbc59f2ez38e0z4eb8z81edz73b983135b41
|
| 4 |
Nasim Rahimi-Farsi, Fatemeh Bostanian, Taha Shahbazi, Fatemeh Sadat Shamsinejad, Mansoor Bolideei, Parvin Mohseni, Alireza Zangooie, Farnaz Boustani, Hamed Shoorei. Novel oncogenes and tumor suppressor genes in Hepatocellular Carcinoma: Carcinogenesis, progression, and therapeutic targets. Gene 2025; 941 doi: 10.1016/j.gene.2025.149229
|
| 5 |
Xingxing He, Fang Liu, Jingjun Yan, Yunan Zhang, Junwei Yan, Haitao Shang, Qian Dou, Qiu Zhao, Yuhu Song. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo. Scientific Reports 2015; 5(1) doi: 10.1038/srep08705
|
| 6 |
Patrick W. Narkwa, David J. Blackbourn, Mohamed Mutocheluh. Aflatoxin B1 inhibits the type 1 interferon response pathway via STAT1 suggesting another mechanism of hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0127-8
|
| 7 |
Leila Valanejad, Kyle Lewis, Mary Wright, Yanjun Jiang, Amber D’Souza, Rebekah Karns, Rachel Sheridan, Anita Gupta, Kevin Bove, David Witte, James Geller, Gregory Tiao, David L. Nelson, Lubov Timchenko, Nikolai Timchenko. FXR-Gankyrin axis is involved in development of pediatric liver cancer. Carcinogenesis 2017; 38(7) doi: 10.1093/carcin/bgx050
|
| 8 |
Katherine S. Koch, Shin Maeda, Guobin He, Michael Karin, Hyam L. Leffert. Targeted deletion of hepatocyte Ikkβ confers growth advantages. Biochemical and Biophysical Research Communications 2009; 380(2) doi: 10.1016/j.bbrc.2009.01.085
|
| 9 |
Shelby Lynn Hophan, Olena Odnokoz, Huiping Liu, Yuan Luo, Seema Khan, William Gradishar, Zhuan Zhou, Sunil Badve, Mylin A Torres, Yong Wan. Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management. Endocrinology 2022; 163(4) doi: 10.1210/endocr/bqac027
|
| 10 |
Hyun-seok Kim, Priya B. Shetty, Spiridon Tsavachidis, Jing Dong, Christopher I. Amos, Hashem B. El-Serag, Aaron P. Thrift. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis. Clinical Gastroenterology and Hepatology 2023; 21(4) doi: 10.1016/j.cgh.2022.05.020
|
| 11 |
Danmei Yu, Zhou Lu, Ruyu Wang, Yusen Xiang, Hongtao Li, Jiani Lu, Lijun Zhang, Hongzhuan Chen, Weihua Li, Xin Luan, Lili Chen. FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy. Biochemical Pharmacology 2023; 212 doi: 10.1016/j.bcp.2023.115570
|
| 12 |
Yuan-Chi Teng, Zhao-Qing Shen, Cheng-Heng Kao, Ting-Fen Tsai. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World Journal of Gastroenterology 2016; 22(1): 300-325 doi: 10.3748/wjg.v22.i1.300
|
| 13 |
. 2021; doi: 10.70675/45531b6dzd430z4410zab75z5647dfe60215
|
| 14 |
Jiaye Mo, Da Gong, Mei Zhai, Jintao Yang, Zhike Li, Meilong Wu, Xuesong Deng, Xiaoyong Dai. The application of liver cancer organoids in tumour precision medicine: A comprehensive review. iLIVER 2025; 4(3) doi: 10.1016/j.iliver.2025.100179
|
| 15 |
Igor P. Pogribny, Levan Muskhelishvili, Volodymyr P. Tryndyak, Frederick A. Beland. The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2011; 722(2) doi: 10.1016/j.mrgentox.2010.02.011
|
| 16 |
Xia Pu, Qing-Xi Guo, Han-An Long, Cheng-Wan Yang. Effects of mTOR-STAT3 on the migra=tion and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer. Asian Pacific Journal of Tropical Medicine 2014; 7(5) doi: 10.1016/S1995-7645(14)60057-2
|
| 17 |
Yucel Aydin, Milad Chedid, Srinivas Chava, Donkita Danielle Williams, Shuanghu Liu, Curt H. Hagedorn, Suchitra Sumitran-Holgersson, Krzysztof Reiss, Krzysztof Moroz, Hua Lu, Luis A. Balart, Srikanta Dash. RETRACTED ARTICLE: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10087-6
|
| 18 |
Kwei-Yan Liu, Li-Ting Wang, Shih-Hsien Hsu, Shen-Nien Wang. Homeobox Genes and Hepatocellular Carcinoma. Cancers 2019; 11(5) doi: 10.3390/cancers11050621
|
| 19 |
Ashley Cast, Leila Valanejad, Mary Wright, Phuong Nguyen, Anita Gupta, Liqin Zhu, Soona Shin, Nikolai Timchenko. C/EBPα‐dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer. Hepatology 2018; 67(5) doi: 10.1002/hep.29677
|
| 20 |
Alexandru Blidisel, Iasmina Marcovici, Dorina Coricovac, Florin Hut, Cristina Adriana Dehelean, Octavian Marius Cretu. Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective. Cancers 2021; 13(15) doi: 10.3390/cancers13153651
|
| 21 |
Hye Jin Kim, Hwa Seung Yoo, Jin Chul Kim, Chan Su Park, Mi Sun Choi, Mijee Kim, Hyangsoon Choi, Jung Sun Min, Yong Soo Kim, Seong Woo Yoon, Jeong Keun Ahn. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Journal of Ethnopharmacology 2009; 124(2) doi: 10.1016/j.jep.2009.04.046
|
| 22 |
Maria Noutsou, Afonso M.S. Duarte, Zeinab Anvarian, Tatiana Didenko, David P. Minde, Ineke Kuper, Isabel de Ridder, Christina Oikonomou, Assaf Friedler, Rolf Boelens, Stefan G.D. Rüdiger, Madelon M. Maurice. Critical Scaffolding Regions of the Tumor Suppressor Axin1 Are Natively Unfolded. Journal of Molecular Biology 2011; 405(3) doi: 10.1016/j.jmb.2010.11.013
|
| 23 |
Anh Tuan Nguyen, Alexander Emelyanov, Chor Hui Vivien Koh, Jan M. Spitsbergen, Siew Hong Lam, Sinnakaruppan Mathavan, Serguei Parinov, Zhiyuan Gong. A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish. Disease Models & Mechanisms 2011; 4(6) doi: 10.1242/dmm.007831
|
| 24 |
Kajal Chakraborty, Prima Francis. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells. Bioorganic Chemistry 2021; 114 doi: 10.1016/j.bioorg.2021.105119
|
| 25 |
Linyou Cheng, Ming Liu, Cuicui Wang, Haizhou Liu, Yuyan Zhang, Xiukun Lin. CI431, an Aqueous Compound from Ciona intestinalis L., Induces Apoptosis through a Mitochondria‐Mediated Pathway in Human Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2011; 2011(1) doi: 10.1155/2011/292873
|
| 26 |
Snežana Jovanović-Ćupić, Milena Krajnović, Lidija Todorović, Ana Božović, Daniel Galun. HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives. Biomedicines 2026; 14(6) doi: 10.3390/biomedicines14061295
|
| 27 |
Shugo Suzuki, Pornsiri Pitchakarn, Kentaro Takeshita, Makoto Asamoto, Satoru Takahashi, Shinya Sato, Tomoyuki Shirai. Roles for Rat Hepatocyte Malignant Transforming Factor (HMTF) in Late Stage of Hepatocarcinogenesis. Toxicologic Pathology 2011; 39(7) doi: 10.1177/0192623311422077
|
| 28 |
Kyle Lewis, Leila Valanejad, Ashley Cast, Mary Wright, Christina Wei, Polina Iakova, Lauren Stock, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner. Molecular and Cellular Biology 2017; 37(16) doi: 10.1128/MCB.00128-17
|
| 29 |
Masahiro Murakami, Shogo Kobayashi, Shigeru Marubashi, Yoshito Tomimaru, Takehiro Noda, Hiroshi Wada, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano. Tyrosine Kinase Inhibitor PTK/ZK Enhances the Antitumor Effects of Interferon-α/5-Fluorouracil Therapy for Hepatocellular Carcinoma Cells. Annals of Surgical Oncology 2011; 18(2) doi: 10.1245/s10434-010-1310-y
|
| 30 |
Stefano Sdogati, Serenella Orsini, Rita Bibi, Angela Caporali, Tommaso Pacini, Emanuela Verdini, Teresa D'Amore, Ivan Pecorelli. Aflatoxin B1, B2, G1, G2, Zearalenone, and Ochratoxin A in Cereals, Cereal‐Based Products and Baby Food: Method Validation, Monitoring Study and Exposure Assessment of the Italian Population. Food Science & Nutrition 2026; 14(4) doi: 10.1002/fsn3.71691
|
| 31 |
Yue Jia, Ping Ji, Barbara French, Brittany Tillman, Samuel W. French. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH). Experimental and Molecular Pathology 2019; 108 doi: 10.1016/j.yexmp.2019.04.002
|
| 32 |
ABDU SELIM HAMID, ISAIAS GOITOM TESFAMARIAM, YUCHENG ZHANG, ZHEN GUI ZHANG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncology Letters 2013; 5(4) doi: 10.3892/ol.2013.1169
|
| 33 |
Carmen Herencia, Julio M. Martínez-Moreno, Concepción Herrera, Fernando Corrales, Raquel Santiago-Mora, Isabel Espejo, Monserrat Barco, Yolanda Almadén, Manuel de la Mata, Antonio Rodríguez-Ariza, Juan R. Muñoz-Castañeda, Cara Gottardi. Nuclear Translocation of β-Catenin during Mesenchymal Stem Cells Differentiation into Hepatocytes Is Associated with a Tumoral Phenotype. PLoS ONE 2012; 7(4) doi: 10.1371/journal.pone.0034656
|
| 34 |
Meixia Zhang, Hongliang Zhang, Chunyan Sun, Xiaolei Shan, Xiaolin Yang, Jesse Li-Ling, Yihui Deng. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemotherapy and Pharmacology 2009; 63(4) doi: 10.1007/s00280-008-0780-0
|
| 35 |
Hyun Jin Song, Xinyi Jiang, Linda Henry, Mindie H. Nguyen, Haesuk Park. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 2020; 76(6) doi: 10.1007/s00228-020-02854-8
|
| 36 |
BIN ZHAO, YUETING ZHU, KAI CUI, JIE GAO, FACHANG YU, LIANG CHEN, SHENG LI. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma. Molecular Medicine Reports 2013; 7(5) doi: 10.3892/mmr.2013.1406
|
| 37 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; doi: 10.1007/978-3-319-26956-6_166
|
| 38 |
Dan Huang, Xiansong Wang, Yingzhi Liu, Ziheng Huang, Xiaoxu Hu, Wei Hu, Qing Li, Hung Chan, Yidan Zou, Idy H T Ho, Yan Wang, Alfred S L Cheng, Wei Kang, Ka F To, Maggie H T Wang, Sunny H Wong, Jun Yu, Tony Gin, Qingpeng Zhang, Zheng Li, Jianxiong Shen, Lin Zhang, Matthew T V Chan, Xiaodong Liu, William K K Wu. Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance. Briefings in Bioinformatics 2021; 22(5) doi: 10.1093/bib/bbab040
|
| 39 |
Ayma Aftab, Humera Naveed, Habiba Idrees, Liaqat Ali, Muhammad Idrees, Samia Afzal. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma. Gastrointestinal Tumors 2025; 12(1) doi: 10.48130/git-0025-0007
|
| 40 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 41 |
Y.‐H. J. Shao, T.‐S. Chan, K. Tsai, S.‐Y. Wu. Association between proton pump inhibitors and the risk of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2018; 48(4) doi: 10.1111/apt.14835
|
| 42 |
Mohamed Mutocheluh, Patrick Williams Narkwa. Aflatoxins - Occurrence, Detection and Novel Detoxification Strategies. 2022; doi: 10.5772/intechopen.106833
|
| 43 |
Rency S. Varghese, Megan E. Barefoot, Sidharth Jain, Yifan Chen, Yunxi Zhang, Amber Alley, Alexander H. Kroemer, Mahlet G. Tadesse, Deepak Kumar, Zaki A. Sherif, Habtom W. Ressom. Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.708326
|
| 44 |
Amber M. D’Souza, Yanjun Jiang, Ashley Cast, Leila Valanejad, Mary Wright, Kyle Lewis, Meenasri Kumbaji, Sheeniza Shah, David Smithrud, Rebekah Karns, Soona Shin, Nikolai Timchenko. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation. Cellular and Molecular Gastroenterology and Hepatology 2018; 6(3) doi: 10.1016/j.jcmgh.2018.05.007
|
| 45 |
|
| 46 |
Ramesh P Thylur, Sanjit K Roy, Anju Shrivastava, Thomas A LaVeist, Sharmila Shankar, Rakesh K Srivastava. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma . JGH Open 2020; 4(3) doi: 10.1002/jgh3.12336
|
| 47 |
Mika Kosaka, Moo Rim Kang, Glen Yang, Long-Cheng Li.
Targeted p21
WAF1/CIP1
Activation by RNAa Inhibits Hepatocellular Carcinoma Cells
. Nucleic Acid Therapeutics 2012; 22(5) doi: 10.1089/nat.2012.0354
|
| 48 |
Xiaobo Nie, Yiran Liu, Wei-Dong Chen, Yan-Dong Wang. Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00657
|
| 49 |
Ganganapalli Supraja, Kalisetty Chengaiahgari Maheswari, Deepika Pamarthy, Kallimakula Venkata Reddy Saritha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00006-9
|
| 50 |
Diren Beyoğlu, Kristopher W. Krausz, Juliette Martin, Olivier Maurhofer, Juliane Dorow, Uta Ceglarek, Frank J. Gonzalez, Jean-François Dufour, Jeffrey R. Idle. Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of Lipid Research 2014; 55(11) doi: 10.1194/jlr.M050682
|
| 51 |
Solomon E. Owumi, Moses T. Otunla, Oyindamola O. Elerewe, Uche O. Arunsi. Co-exposure to aflatoxin B1 and therapeutic coartem worsens hepatic and renal function through enhanced oxido-inflammatory responses and apoptosis in rats. Toxicon 2023; 222 doi: 10.1016/j.toxicon.2022.106988
|
| 52 |
Ke Su, Chun-Fang Wang, Ying Zhang, Yu-Jie Cai, Yan-Yan Zhang, Qian Zhao. miR-940 upregulation contributes to human cervical cancer progression through p27 and PTEN inhibition. International Journal of Oncology 2017; 50(4) doi: 10.3892/ijo.2017.3897
|
| 53 |
Ummi Maimunah, Andreas Agung Kurniawan, Andrio Palayukan. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(1) doi: 10.61873/WWAY6273
|
| 54 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 55 |
Wu-Lung R. Yang, Yu-En Lee, Ming-Huang Chen, Kun-Mao Chao, Chi-Ying F. Huang. In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result. Gene 2013; 518(1) doi: 10.1016/j.gene.2012.11.030
|
| 56 |
Wayne Y. W. Lee, Chartia C. M. Cheung, Ken W. K. Liu, K. P. Fung, John Wong, Paul B. S. Lai, John H. K. Yeung. Cytotoxic Effects of Tanshinones fromSalvia miltiorrhizaon Doxorubicin-Resistant Human Liver Cancer Cells. Journal of Natural Products 2010; 73(5) doi: 10.1021/np900792p
|
| 57 |
Leila Valanejad, Ashley Cast, Mary Wright, Karl-Dimiter Bissig, Rebekah Karns, Matthew T. Weirauch, Nikolai Timchenko. PARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastoma. Communications Biology 2018; 1(1) doi: 10.1038/s42003-018-0077-8
|
| 58 |
Lu Zheng, Chang-Lin Deng, Liang Wang, Xiao-Bing Huang, Nan You, Yi-Chen Tang, Ke Wu, Ping Liang, Na Mi, Jing Li. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma. Oncotarget 2016; 7(22) doi: 10.18632/oncotarget.9047
|
| 59 |
Michael Dare Asemoloye, Segun Gbolagade Jonathan, Rashid Saddaf, Zaffar Habiba, Edward Ehidiabhen Okoawo, Tunde Sheriffdeen Bello. Aflatoxin-Control, Analysis, Detection and Health Risks. 2017; doi: 10.5772/intechopen.68478
|
| 60 |
Yongfeng Wang, Jin Cheng, Chunhui Xu, Shuang Liu, Suzhen Jiang, Qiang Xu, Xiangmei Chen, Hui Zhuang, Fengmin Lu. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus‐related hepatocellular carcinoma. Liver International 2012; 32(3) doi: 10.1111/j.1478-3231.2011.02696.x
|
| 61 |
Kin Tak Chan, Fan Yan Meng, Qian Li, Cheong Yip Ho, Tsz Shan Lam, Yu To, Wai Him Lee, Miao Li, Kee Hung Chu, Melvin Toh. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Letters 2010; 294(1) doi: 10.1016/j.canlet.2010.01.029
|
| 62 |
Shelli M. Morris, Ji Yeon Baek, Amanda Koszarek, Samornmas Kanngurn, Sue E. Knoblaugh, William M. Grady. Transforming Growth Factor–Beta Signaling Promotes Hepatocarcinogenesis Induced by P53 Loss. Hepatology 2012; 55(1) doi: 10.1002/hep.24653
|
| 63 |
Jafar Ai, Neda Ketabchi, Javad Verdi, Nematollah Gheibi, Hossein Khadem Haghighian, Maria Kavianpour. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1038-0
|
| 64 |
Lan Sun, Xiaona Zhou, Yanmeng Li, Wei Chen, Shanna Wu, Bei Zhang, Jingyi Yao, Anjian Xu. KLF5 regulates epithelial-mesenchymal transition of liver cancer cells in the context of p53 loss through miR-192 targeting of ZEB2. Cell Adhesion & Migration 2020; 14(1) doi: 10.1080/19336918.2020.1826216
|
| 65 |
Anne-Christine Piguet, Jean-François Dufour. PI(3)K/PTEN/AKT pathway. Journal of Hepatology 2011; 54(6) doi: 10.1016/j.jhep.2010.12.013
|
| 66 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; doi: 10.1007/978-3-319-26587-2_166-1
|
| 67 |
Sheau-Fang Yang, Chien-Wei Chang, Ren-Jie Wei, Yow-Ling Shiue, Shen-Nien Wang, Yao-Tsung Yeh. Involvement of DNA Damage Response Pathways in Hepatocellular Carcinoma. BioMed Research International 2014; 2014 doi: 10.1155/2014/153867
|
| 68 |
Qijiong Li, Xiaofeng Liu, Kemin Jin, Min Lu, Chunfeng Zhang, Xiaojuan Du, Baocai Xing. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3570-4
|
| 69 |
Gang Wang, Xuefeng Li, Hongyan Jia, Lei Zhang, Yang Li, Qiuxue Zhang, Meng Lu. Curcumin nanocarrier carrying si-TAR-RNA binding protein (TRBP) restricts development of hepatocellular carcinoma. Materials Express 2023; 13(3) doi: 10.1166/mex.2023.2368
|
| 70 |
KURT SARTORIUS, BENN SARTORIUS, CHERIE WINKLER, ANIL CHUTURGOON, ANNA KRAMVIS, PING AN, WEIGANG ZHANG, YUNJIE LU. The roles and mechanisms of miRNA in HBV-HCC carcinogenesis: Why no therapeutic agents after 30 years?. BIOCELL 2024; 48(11) doi: 10.32604/biocell.2024.055505
|
| 71 |
Teresa Davoli, Titia de Lange. The Causes and Consequences of Polyploidy in Normal Development and Cancer. Annual Review of Cell and Developmental Biology 2011; 27(1) doi: 10.1146/annurev-cellbio-092910-154234
|
| 72 |
. 2019; doi: 10.70675/eef9404azffadz4212z9948z699104f7c1ab
|
| 73 |
Baoying Hu, Yicheng Xiong, Runzhou Ni, Lixian Wei, Dawei Jiang, Gang Wang, Di Wu, Tianxin Xu, Fengbo Zhao, Mingyan Zhu, Chunhua Wan. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2014; 396(1-2) doi: 10.1007/s11010-014-2153-9
|